Feature Channels: Autoimmune Diseases

Filters close
Released: 12-Jul-2023 6:30 PM EDT
Researchers report advance in immune therapy against ALS
University of California, Los Angeles (UCLA), Health Sciences

New research suggests that targeting autoimmune inflammation associated with amyotrophic lateral sclerosis (ALS) using two drugs, one of them already approved for multiple sclerosis, could be a promising approach for treatment.

Newswise: UM Neurologists Lead Groundbreaking Myasthenia Gravis Cellular Therapy Study Published in Lancet Neurology
Released: 30-Jun-2023 1:05 PM EDT
UM Neurologists Lead Groundbreaking Myasthenia Gravis Cellular Therapy Study Published in Lancet Neurology
University of Miami Health System, Miller School of Medicine

A new study led by two neurologists at the University of Miami Miller School of Medicine points to a potential novel form of Car T cellular therapy for myasthenia gravis (MG), a chronic autoimmune disorder characterized by muscle weakness. The study findings were recently published in the British journal Lancet Neurology.

Newswise:Video Embedded proteins-predict-significant-step-toward-development-of-diabetes
VIDEO
28-Jun-2023 3:00 PM EDT
Proteins Predict Significant Step Toward Development of Diabetes
Pacific Northwest National Laboratory

Scientists have taken an important step forward in predicting who will develop Type 1 diabetes months before symptoms appear.

Newswise:Video Embedded scleroderma-awareness-month
VIDEO
Released: 27-Jun-2023 12:30 PM EDT
Scleroderma Awareness Month
Cedars-Sinai

Scleroderma is an autoimmune disease characterized by thickening and scarring of the skin and vital organs, and the narrowing of the blood vessels which lead to poor circulation.

Newswise: UTHealth Houston Study on Repeated Radiofrequency Ablation in Combination with Chemotherapy for Pancreatic Cancer Supported with $3.3M HHS Grant
Released: 20-Jun-2023 5:25 PM EDT
UTHealth Houston Study on Repeated Radiofrequency Ablation in Combination with Chemotherapy for Pancreatic Cancer Supported with $3.3M HHS Grant
University of Texas Health Science Center at Houston

A combination strategy of endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) with chemotherapy for pancreatic cancer will be studied at UTHealth Houston through a $3.3 million grant from the National Cancer Institute by the U.S. Department of Health and Human Services.

Released: 20-Jun-2023 5:20 PM EDT
Rensselaer Researcher To Investigate the Mechanics of Mitosis To Combat Cancer
Rensselaer Polytechnic Institute (RPI)

It is a scary fact that one in two women and one in three men in the United States will develop some form of cancer in their lifetime. One of the hallmarks of many cancers is the occurrence of errors during the cell division process called mitosis. Therefore, critical to enhancing treatments or perhaps even finding a cure for cancer and other diseases, is developing a better understanding of how mitosis works in both healthy and diseased cells.

Released: 13-Jun-2023 1:10 PM EDT
Why women with multiple sclerosis get better when pregnant
Linkoping University

Women suffering from the autoimmune disease multiple sclerosis temporarily get much better when pregnant. Researchers have now identified the beneficial changes naturally occurring in the immune system during pregnancy.

Newswise: SLU Medical Student Receives NIH F30 Grant to Explore Autoimmune Disease, Infection in the Stomach
Released: 8-Jun-2023 5:00 PM EDT
SLU Medical Student Receives NIH F30 Grant to Explore Autoimmune Disease, Infection in the Stomach
Saint Louis University

Stella Hoft, a M.D./Ph.D. student at Saint Louis University’s School of Medicine, was recently awarded a F30 Grant through the National Institute of Diabetes & Digestive & Kidney Diseases.

Newswise: SLU Researcher Receives $2.2 M to Study Link Between Inflammation, Gastric Cancer
Released: 8-Jun-2023 4:30 PM EDT
SLU Researcher Receives $2.2 M to Study Link Between Inflammation, Gastric Cancer
Saint Louis University

Rich DiPaolo, Ph.D., professor and interim chair in the Department of Molecular Microbiology and Immunology, warns that patients with gastritis caused by autoimmunity as well as Helicobacter pylori, a type of bacteria that infects your stomach, may benefit from routine screenings to identify patients with a high risk of progressing to gastric cancer.

Released: 8-Jun-2023 7:00 AM EDT
Usar IA para predecir la insuficiencia renal en pacientes con enfermedad renal poliquística
Mayo Clinic

La insuficiencia renal puede tener diversas causas: diabetes, presión arterial alta, enfermedades autoinmunitarias y enfermedad renal poliquística o ERP.

Released: 8-Jun-2023 7:00 AM EDT
Uso de IA para prever insuficiência renal em pacientes com doença renal policística
Mayo Clinic

A insuficiência renal pode ser causada por diversos motivos: diabetes, pressão arterial elevada, doenças autoimunes e doença renal policística ou DRP.

Released: 8-Jun-2023 7:00 AM EDT
استخدام الذكاء الاصطناعي للتنبؤ بالفشل الكلوي لدى المرضى المصابين بداء الكلى متعددة الكيسات
Mayo Clinic

قد ينتج الفشل الكلوي عن عدة أسباب منها، السكري وارتفاع ضغط الدم، وأمراض المناعة الذاتية، وداء الكلى متعددة الكيسات.

Newswise: NUS researchers invent powerful tool to gather data on immune response at single-cell level
Released: 5-Jun-2023 11:05 PM EDT
NUS researchers invent powerful tool to gather data on immune response at single-cell level
National University of Singapore (NUS)

Scientists from the National University of Singapore have invented a powerful tool that captures data on immune cell response at a single-cell level. This groundbreaking technique will accelerate the discovery of new immunotherapies to treat diseases such as cancer, autoimmune disorders, and infectious diseases.

   
Newswise: Pumping the brakes on autoimmune disease
Released: 5-Jun-2023 11:00 AM EDT
Pumping the brakes on autoimmune disease
Sanford Burnham Prebys

A new study from researchers at Sanford Burnham Prebys and Eli Lilly and Company describes the science behind an autoimmune disease treatment in a Phase 2 clinical trial.

Newswise: 'Tipping The Balance’ Of Immune Cells from Bad to Good Reverses Multiple Sclerosis Symptoms in Mice
Released: 2-Jun-2023 2:20 PM EDT
'Tipping The Balance’ Of Immune Cells from Bad to Good Reverses Multiple Sclerosis Symptoms in Mice
Johns Hopkins Medicine

According to the federal government’s National Institute of Neurological Disorders and Stroke, nearly 3 million people worldwide — with almost a third in the United States — are living with multiple sclerosis (MS), a disabling neurological disease in which the body’s immune system mistakenly attacks nerves feeding information to the central nervous system (the brain and spinal cord). Although rarely fatal, MS can lead to long-term disabilities, and impair movement, muscle control, vision and cognition.

Newswise: Simposio Pone de Relieve la Investigación Sobre Diferencias Sexuales
Released: 30-May-2023 4:25 PM EDT
Simposio Pone de Relieve la Investigación Sobre Diferencias Sexuales
Cedars-Sinai

Todo lo que los médicos e investigadores saben acerca de la medicina, desde qué medicamentos recetar hasta cómo realizar las cirugías, se basa en la investigación. Pero durante décadas, la mayor parte de este trabajo ha dejado de lado a las participantes femeninas.

23-May-2023 10:05 AM EDT
CHOP Researchers Show that IgA Fine Tunes the Body’s Interactions with Microbes
Children's Hospital of Philadelphia

A new study by researchers at Children’s Hospital of Philadelphia (CHOP) has demonstrated that IgA acts as a “tuner” that regulates the number of microbes the body sees every day, restraining the systemic immune response to these commensal microbes and limiting the development of systemic immune dysregulation.

22-May-2023 11:00 AM EDT
In 2050, over 800 million people globally estimated to be living with back pain
University of Sydney

Study estimates there will be over 800 million cases of low back pain in 2050, a 36 percent increase from 2020. With an ageing population, researchers say we must ‘put the brakes’ on low back pain cases before the burden becomes too great for our healthcare system.

Released: 22-May-2023 4:40 PM EDT
TAp63: A new protein drug target for rheumatoid arthritis
Chiba University

Rheumatoid arthritis (RA) is an autoimmune disease characterized by joint deterioration. The clinical outcomes of patients with active RA can be improved using anti-rheumatic medications, such as methotrexate (MTX).

Released: 17-May-2023 2:40 PM EDT
Researchers identify potential new strategy to prevent side effects from immunotherapy
University of California, Los Angeles (UCLA), Health Sciences

A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center suggests that IL-21, a soluble molecule involved in activating the immune system, can be a potential therapeutic target to help reduce endocrine autoimmune side effects caused by checkpoint inhibitor cancer therapy.

Released: 16-May-2023 2:00 PM EDT
May is Melanoma and Skin Cancer Awareness Month. Keep up with the latest news on skin in the Dermatology channel
Newswise

Skin cancer is the most prevalent form of cancer in the United States, with over 5 million cases diagnosed annually. The Centers for Disease Control and Prevention reports that melanoma alone accounts for more than 8,000 deaths each year. Thankfully, skin cancer is highly preventable, making it crucial to prioritize protection. Below are some of the latest headlines in the Dermatology channel.

Newswise: Antibodies associated with rare disorder may signal future risk of heart attack and stroke
Released: 16-May-2023 8:05 AM EDT
Antibodies associated with rare disorder may signal future risk of heart attack and stroke
UT Southwestern Medical Center

Seemingly healthy people whose blood contained antibodies associated with a condition called antiphospholipid syndrome (APS) were significantly more likely to experience a cardiovascular event such as a heart attack or stroke than those without, a study led by UT Southwestern Medical Center scientists shows

Released: 10-May-2023 1:25 PM EDT
Hackensack Meridian JFK University Medical Center Welcomes Otolaryngologist and Thoracic Surgeon to Advanced Lung & Airway Center
Hackensack Meridian Health

“We are delighted to welcome Dr. Razi and Dr. Lebovics to our team of experts at JFK University Medical Center who treat patients with breathing disorders,” said Faiz Y. Bhora, MD, FACS, Professor and Regional Chair of Surgery, Central Region, Hackensack Meridian Health and Hackensack Meridian School of Medicine, who leads the Advanced Lung & Airway Center.

Newswise: The Acute Problem of Chronic Disease
Released: 10-May-2023 1:05 PM EDT
The Acute Problem of Chronic Disease
University of California San Diego

In medicine and science, the term “pathogenesis” describes the origin and development of disease. There is not, however, a broadly accepted term to describe the other half of the equation: the process of healing and recovery.

Newswise: Association of American Physicians Taps Cedars-Sinai Leader as President-Elect
Released: 3-May-2023 1:40 PM EDT
Association of American Physicians Taps Cedars-Sinai Leader as President-Elect
Cedars-Sinai

Physician-scientist Paul Noble, MD, chair of the Department of Medicine at Cedars-Sinai, was named president-elect of the Association of American Physicians (AAP) at the group's annual meeting in Chicago on April 22.

Released: 2-May-2023 2:30 PM EDT
Climate change affecting allergies, and other allergy news
Newswise

For millions of Americans that suffer from seasonal allergies (pollen and mold), climate change is exacerbating an earlier, longer, and overall worse allergy season.

Newswise: April Research Highlights
Released: 28-Apr-2023 4:50 PM EDT
April Research Highlights
Cedars-Sinai

A roundup of the latest medical discoveries and faculty news at Cedars-Sinai for April 2023.

Newswise: Too Much Insulin Can Be as Dangerous as Too Little
Released: 21-Apr-2023 5:35 PM EDT
Too Much Insulin Can Be as Dangerous as Too Little
University of California San Diego

UC San Diego researchers describe a key player in the defense mechanism that safeguards against excessive insulin in the body, which can be as harmful as too little.

Newswise:Video Embedded live-event-for-april-21-sleeping-pill-reduces-levels-of-alzheimer-s-proteins
VIDEO
Released: 21-Apr-2023 3:10 PM EDT
TRANSCRIPT AND VIDEO AVAILABLE Live Event for April 21: Sleeping pill reduces levels of Alzheimer’s proteins
Newswise

Researcher will discuss the study which involved a sleeping aid known as suvorexant that is already approved by the Food and Drug Administration (FDA) for insomnia, hints at the potential of sleep medications to slow or stop the progression of Alzheimer’s disease.

       
Newswise: Skin conditions may indicate more serious rheumatic disease, UT Southwestern physician says
Released: 21-Apr-2023 11:05 AM EDT
Skin conditions may indicate more serious rheumatic disease, UT Southwestern physician says
UT Southwestern Medical Center

While rheumatic diseases typically affect the joints, muscles, or ligaments, the first signs of a problem may appear on the skin. A UT Southwestern physician who specializes in rheumatology says it’s essential to know what to look for.

Newswise: nPOD honors Estefania Quesada Masachs for type 1 diabetes discoveries
Released: 17-Apr-2023 12:45 PM EDT
nPOD honors Estefania Quesada Masachs for type 1 diabetes discoveries
La Jolla Institute for Immunology

La Jolla Institute for Immunology (LJI) Instructor Estefania Quesada Masachs, M.D., Ph.D., has won the 2023 Young Investigator of the Year Award from the Network for Pancreatic Organ donors with Diabetes (nPOD). This prestigious award recognizes Quesada Masachs' groundbreaking research in type 1 diabetes.

   
Newswise: Study sheds light on how IBD can develop
Released: 7-Apr-2023 5:35 PM EDT
Study sheds light on how IBD can develop
University of California, Riverside

Inflammatory bowel disease, or IBD, describes Crohn’s disease and ulcerative colitis, two chronic diseases that cause inflammation in the intestines. IBD, which affects about 3 million adults in the United States, is an autoimmune disorder — a condition in which the body’s immune system attacks healthy tissues.

3-Apr-2023 3:30 PM EDT
CHOP-led Study Identifies Two Different Regulatory T Cell Populations
Children's Hospital of Philadelphia

A regulatory class of human T cells descends from two different origins, one that relates to autoimmunity and one that relates to protective immunity, according to a new study led by Children’s Hospital of Philadelphia (CHOP). The findings, published today in Science Immunology, could pave the way for new treatments for autoimmune diseases that target the immune system selectively.

Released: 5-Apr-2023 10:05 AM EDT
Kovler Diabetes Center raises over $35K for diabetes care and research at Salon Kovler event
University of Chicago Medical Center

The University of Chicago Medicine Kovler Diabetes Center raised more than $35,000 at its annual Salon Kovler event, which supports the health system's critical diabetes care and research initiatives that are focused on reducing healthcare disparities. The March 9 fundraiser and educational program at Navy Pier brought together community stakeholders, corporate leaders, and UChicago Medicine faculty and staff for a conversation about diabetes disparities and how to overcome them.

Released: 5-Apr-2023 10:05 AM EDT
Antiphospholipid antibodies may increase heart disease risk in healthy people
Michigan Medicine - University of Michigan

Research suggests these antibodies may be present in seemingly healthy people, increasing their risk of a heart attack or stroke over time.

Newswise: Researchers Announce Findings from Landmark Clinical Trial for Pediatric Crohn’s Disease
Released: 3-Apr-2023 5:15 PM EDT
Researchers Announce Findings from Landmark Clinical Trial for Pediatric Crohn’s Disease
University of North Carolina Health Care System

A significant clinical trial under the direction of Michael Kappelman, MD, MPH, professor of pediatrics at UNC School of Medicine, found that patients receiving the tumor necrosis factor inhibitor adalimumab combined with a low dose of methotrexate, a second immunosuppressant, did better than those treated with infliximab alone. Patients who received infliximab, another tumor necrosis factor inhibitor, had similar outcomes with or without methotrexate.

Released: 29-Mar-2023 1:25 PM EDT
Novel anti-NET antibodies in a multinational cohort
Michigan Medicine - University of Michigan

Antiphospholipid syndrome is a understudied autoimmune disease that is nevertheless a leading causes of deadly blood clots and late-term pregnancy loss. An international study led by the University of Michigan researchers Ray Zuo, M.D., and Jason Knight, M.D., Ph.D., has discovered a new class of functional autoantibodies in APS patients that contributes to the disease's development and the systemic inflammation it induces.

Released: 28-Mar-2023 2:20 PM EDT
From the doctor's office to the operating room: Keep up with the latest in healthcare here
Newswise

From septic shock to sticker shock. Keep up with this ever-growing, changing sector. Below are some of the latest stories on healthcare on Newswise.

Newswise: How Are Epstein-Barr Virus and Multiple Sclerosis (MS) Connected?
Released: 23-Mar-2023 9:55 AM EDT
How Are Epstein-Barr Virus and Multiple Sclerosis (MS) Connected?
Ochsner Health

The linking of MS and EBV could be a significant step in gaining the upper hand in the prevention of MS, which affects nearly 1 million people over the age of 18 in the United States.

Released: 20-Mar-2023 9:00 AM EDT
Antibiotic resistance is an increasing problem. Learn all about it in the Drug Resistance channel.
Newswise

Staphylococcus aureus, Clostridioides difficile, Candida auris, Drug-resistant Shigella. These bacteria not only have difficult names to pronounce, but they are also difficult to fight off. These bacteria may infect humans and animals, and the infections they cause are harder to treat than those caused by non-resistant bacteria. Antimicrobial resistance is an urgent global public health threat.

     
Newswise: How Are Multiple Sclerosis and Hardening of the Arteries (Atherosclerosis) Linked?
Released: 17-Mar-2023 11:05 AM EDT
How Are Multiple Sclerosis and Hardening of the Arteries (Atherosclerosis) Linked?
Ochsner Health

While the scleroses are of inherently different composition and cause, and the prevalence of each types of scleroses is not breaking news, their linkage is beginning to make headlines with the emergence of new research.

Released: 15-Mar-2023 5:40 PM EDT
Artificial Sweetener could dampen immune response to disease in mice
Francis Crick Institute

Scientists at the Francis Crick Institute have found that high consumption of a common artificial sweetener, sucralose, lowers activation of T-cells, an important component of the immune system, in mice.

   
Released: 15-Mar-2023 5:05 PM EDT
A common metabolite may help treat autoimmune diseases
Hokkaido University

Researchers have revealed the modulatory effect of the anti-inflammatory metabolite itaconate on T helper and T regulatory cells, which may lead to new therapeutic approaches to treating some autoimmune diseases.

Newswise: Immune cells have a backup mechanism
Released: 10-Mar-2023 5:20 PM EST
Immune cells have a backup mechanism
University of Bonn

The enzyme TBK1 is an important component of the innate immune system that plays a critical role in the defense against viruses. Upon mutation-induced loss of TBK1 function, patients show an increased susceptibility to viral infections.

Newswise: Family’s participation key to advancing diabetes research
Released: 10-Mar-2023 5:10 PM EST
Family’s participation key to advancing diabetes research
Vanderbilt University Medical Center

A study of one family from Alabama has led Vanderbilt University Medical Center researchers to discover that insulin deficiency, independent of the autoimmunity associated with Type 1 diabetes, is the principal factor leading to a markedly smaller pancreas.



close
1.39782